Insights into the acute cerebral metabolic changes associated with childhood diabetes

F J Cameron1, M J Kean, R M Wellard

  • 1Centre for Hormone Research, Melbourne, Australia. fergus.cameron@rch.org.au

Insights

Diabetic ketoacidosis (DKA) in children can cause brain swelling. This study found altered brain metabolism and structure in children with type 1 diabetes, suggesting increased vulnerability to cerebral edema.

Area of Science:

  • Pediatric Endocrinology
  • Neuroscience
  • Medical Imaging

Background:

  • Type 1 diabetes is common in children.
  • Cerebral edema is a major cause of death in pediatric diabetic ketoacidosis (DKA).
  • The underlying cerebral metabolic changes leading to DKA complications are not well understood.

Purpose of the Study:

  • To analyze brain MRI and MRS data in children with diabetes presenting with hyperglycemia and/or DKA.
  • To determine the nature and timing of cerebral structural and metabolic alterations.
  • To investigate potential links between these alterations and DKA pathogenesis.

Main Methods:

  • Utilized Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS).
  • Investigated regional cerebral abnormalities in a small cohort of diabetic children with and without DKA.
  • Compared imaging findings with clinical and biochemical data.

Main Results:

  • All patients showed abnormal frontal lobe signal changes on FLAIR MRI, indicative of edema.
  • Spectroscopic analysis revealed elevated levels of taurine, myoinositol, and glucose.
  • MR abnormalities' severity did not correlate with clinical or biochemical parameters.

Conclusions:

  • Diabetic children, especially at presentation, exhibit cerebral metabolic alterations relevant to DKA complications.
  • Increased taurine levels may signify heightened brain vulnerability to cerebral edema in diabetic children compared to adults.
  • Findings have implications for understanding and treating DKA-related cerebral complications.
Abstract

Related Concept Videos

Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...